Skip to main content
Fig. 2 | BMC Psychiatry

Fig. 2

From: Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database

Fig. 2

Trends in prescribed hypnotics (a) and distribution of baseline hypnotics (b) among new users. The trends in hypnotics prescribed between 2010 and 2019 (a) and the distribution of hypnotics prescribed in 2018–2019 (b) were assessed in new users of hypnotics. *The denominator was the number of patients prescribed BZDs (all BZDs were regarded as a single MOA regardless of the type). †The denominator was the number of patients prescribed multiple MOAs. BZD benzodiazepine, MOA mechanism of action, MRA melatonin receptor agonist, ORA orexin receptor antagonist, z-drug non-benzodiazepine

Back to article page